BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29747697)

  • 1. Low LPA gene kringle IV-2 repeat copy number association with elevated lipoprotein (a) concentration as an independent risk factor of coronary atherosclerotic heart disease in the Chinese Han population.
    Sun L; Zong M; Chen C; Xie L; Wu F; Yu M; Fan L
    Lipids Health Dis; 2018 May; 17(1):111. PubMed ID: 29747697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
    Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
    Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL.
    Li C; Chen Q; Zhang M; Liu Y; Chu Y; Meng F; Wang J; Tang J; Luo J; Niu X; Wei M
    BMC Cardiovasc Disord; 2021 Jan; 21(1):41. PubMed ID: 33468066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians.
    Lanktree MB; Anand SS; Yusuf S; Hegele RA;
    Circ Cardiovasc Genet; 2010 Feb; 3(1):39-46. PubMed ID: 20160194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipoprotein (a) and LPA KIV2 repeat polymorphism in bicuspid aortic valve stenosis and calcification: a proof of concept study.
    Sticchi E; Giusti B; Cordisco A; Gori AM; Sereni A; Sofi F; Mori F; Colonna S; Fugazzaro MP; Pepe G; Nistri S; Marcucci R
    Intern Emerg Med; 2019 Jan; 14(1):45-50. PubMed ID: 30099661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent LPA KIV-2 Variants Lower Lipoprotein(a) Concentrations and Protect Against Coronary Artery Disease.
    Schachtl-Riess JF; Kheirkhah A; Grüneis R; Di Maio S; Schoenherr S; Streiter G; Losso JL; Paulweber B; Eckardt KU; Köttgen A; Lamina C; Kronenberg F; Coassin S;
    J Am Coll Cardiol; 2021 Aug; 78(5):437-449. PubMed ID: 34325833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
    Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
    N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease.
    Kraft HG; Lingenhel A; Köchl S; Hoppichler F; Kronenberg F; Abe A; Mühlberger V; Schönitzer D; Utermann G
    Arterioscler Thromb Vasc Biol; 1996 Jun; 16(6):713-9. PubMed ID: 8640397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LPA and PLG sequence variation and kringle IV-2 copy number in two populations.
    Crawford DC; Peng Z; Cheng JF; Boffelli D; Ahearn M; Nguyen D; Shaffer T; Yi Q; Livingston RJ; Rieder MJ; Nickerson DA
    Hum Hered; 2008; 66(4):199-209. PubMed ID: 18612205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction.
    Coassin S; Erhart G; Weissensteiner H; Eca Guimarães de Araújo M; Lamina C; Schönherr S; Forer L; Haun M; Losso JL; Köttgen A; Schmidt K; Utermann G; Peters A; Gieger C; Strauch K; Finkenstedt A; Bale R; Zoller H; Paulweber B; Eckardt KU; Hüttenhofer A; Huber LA; Kronenberg F
    Eur Heart J; 2017 Jun; 38(23):1823-1831. PubMed ID: 28444229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.
    Coassin S; Kronenberg F
    Atherosclerosis; 2022 May; 349():17-35. PubMed ID: 35606073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and nutritional factors determining circulating levels of lipoprotein(a): results of the "Montignoso Study".
    Sereni A; Sticchi E; Gori AM; Magi A; Della Latta D; Volta A; Murri A; Jamagidze G; Chiappino D; Abbate R; Gensini GF; Marcucci R; Sofi F; Giusti B
    Intern Emerg Med; 2020 Oct; 15(7):1239-1245. PubMed ID: 31993950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein(a) Concentration and Risks of Cardiovascular Disease and Diabetes.
    Gudbjartsson DF; Thorgeirsson G; Sulem P; Helgadottir A; Gylfason A; Saemundsdottir J; Bjornsson E; Norddahl GL; Jonasdottir A; Jonasdottir A; Eggertsson HP; Gretarsdottir S; Thorleifsson G; Indridason OS; Palsson R; Jonasson F; Jonsdottir I; Eyjolfsson GI; Sigurdardottir O; Olafsson I; Danielsen R; Matthiasson SE; Kristmundsdottir S; Halldorsson BV; Hreidarsson AB; Valdimarsson EM; Gudnason T; Benediktsson R; Steinthorsdottir V; Thorsteinsdottir U; Holm H; Stefansson K
    J Am Coll Cardiol; 2019 Dec; 74(24):2982-2994. PubMed ID: 31865966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality.
    Kamstrup PR; Tybjærg-Hansen A; Nordestgaard BG
    Scand J Clin Lab Invest; 2011 Apr; 71(2):87-93. PubMed ID: 21231777
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Mu-Han-Ha-Li 迪丽达尔 木汗哈力 DL; Zhai 翟天羽 TY; Ling 凌雁 Y; Gao 高鑫 X
    J Lipid Res; 2018 May; 59(5):884-891. PubMed ID: 29511049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.
    Burgess S; Ference BA; Staley JR; Freitag DF; Mason AM; Nielsen SF; Willeit P; Young R; Surendran P; Karthikeyan S; Bolton TR; Peters JE; Kamstrup PR; Tybjærg-Hansen A; Benn M; Langsted A; Schnohr P; Vedel-Krogh S; Kobylecki CJ; Ford I; Packard C; Trompet S; Jukema JW; Sattar N; Di Angelantonio E; Saleheen D; Howson JMM; Nordestgaard BG; Butterworth AS; Danesh J;
    JAMA Cardiol; 2018 Jul; 3(7):619-627. PubMed ID: 29926099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kringle IV Type 2, Not Low Lipoprotein(a), as a Cause of Diabetes: A Novel Genetic Approach Using SNPs Associated Selectively with Lipoprotein(a) Concentrations or with Kringle IV Type 2 Repeats.
    Tolbus A; Mortensen MB; Nielsen SF; Kamstrup PR; Bojesen SE; Nordestgaard BG
    Clin Chem; 2017 Dec; 63(12):1866-1876. PubMed ID: 28971985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence variation within the KIV-2 copy number polymorphism of the human LPA gene in African, Asian, and European populations.
    Noureen A; Fresser F; Utermann G; Schmidt K
    PLoS One; 2015; 10(3):e0121582. PubMed ID: 25822457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms in human apolipoprotein(a) kringle IV-10 and coronary artery disease: relationship to allele size, plasma lipoprotein(a) concentration, and lysine binding site activity.
    Simó JM; Joven J; Vilella E; Ribas M; Figuera L; Virgos C; Sundaram IM; Hoover-Plow J
    J Mol Med (Berl); 2001 Jun; 79(5-6):294-9. PubMed ID: 11485023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-degree sequence conservation in LPA kringle IV-type 2 exons and introns.
    Rösby O; Aleström P; Berg K
    Clin Genet; 1997 Nov; 52(5):293-302. PubMed ID: 9520119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.